CLINICAL_TRIALS ClinicalTrials.gov record update

PROSPER: Prospective Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin-α (TARGAXAN®/XIFAXAN®) 550 mg

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02488993
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:04.006865+00:00
Published At: 2018-12-13T00:00:00+00:00
Record Updated At: 2018-12-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatic Encephalopathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-12-13"
protocolSection.identificationModule.nctId: "NCT02488993"
protocolSection.identificationModule.officialTitle: "PROSPER: Prospective Real World Outcomes Study of Hepatic Encephalopathy Patients\u0027 Experience on Rifaximin-\u03b1 (TARGAXAN\u00ae/XIFAXAN\u00ae) 550 mg"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.